Therapeutic Guidewire Market Analysis

1
Growth of the Global Therapeutic Guidewire Market
to be Propelled by Popular Preference for
Minimally Invasive Surgery (MIS) and Steady
Increase in Target Diseases by CAGR of 6
During 2022 2031 Kenneth Research published a
report titled Therapeutic Guidewire Market
Global Demand Analysis Opportunity Outlook
2031 which delivers detailed overview of the
therapeutic guidewire market in terms of market
segmentation by type, by shape, by application,
by end-user and by region. Further, for the
in-depth analysis, the report encompasses the
industry growth indicators, restraints, supply
and demand risk, along with detailed discussion
on current and future market trends that are
associated with the growth of the market.
The global therapeutic guidewire market is
expected to grow at a CAGR of approximately 6
from 2022-2031. The market is segmented by
application into neurovascular diseases,
peripheral artery disease, urological disease,
and cardiovascular diseases. Out of these, the
cardiovascular disease segment is anticipated to
hold the largest market
2
share by the end of 2031, owing to the global
prevalence of these diseases and the high number
of heart surgeries performed yearly. The global
therapeutic guidewire market is expected to
generate a revenue of USD 4 billion by 2031, up
from approximately USD 2 billion in 2021. The
market growth can be attributed to a universal
preference for minimally invasive surgery (MIS)
and a steady increase in target diseases. A
growing geriatric population, concern about
healthcare- associated infections (HCAI),
investment in healthcare research development
(RD), and technological advancement are the
other factors that propel the growth of the
therapeutic guidewire market. The therapeutic
guidewire market is divided into five major
regions, including North America, Europe, Asia
Pacific, Latin America, and Middle East Africa.
The market in North America is projected to hold
the largest market share by the end of 2031,
backed by the high number of people opting for
minimally invasive surgeries and procedures with
medical reimbursements. Steady Increase in
Target Diseases Globally to Boost the Market
Growth Every year, about 18 million people die as
a result of cardiovascular diseases making these
diseases the prime reason for death globally. The
total number of cases of cardiovascular diseases
to be reported in the U.S. in 2019 increased by
27 compared to 2010. For Detailed
Description_at_https//www.kennethresearch.com/report
-details/global- therapeutic-medical-guidewire-ma
rket/10042864 Similarly based on the studies by
the Centers for Disease Control and Prevention
(CDC), there were high numbers of newly reported
cases of cancer and deaths caused by cancer in
the U.S. in 2019. The numbers were 1,752,735 and
599,589, respectively. At present, more people
are choosing minimally invasive surgeries (MIS)
and diagnostic procedures for their target
diseases over traditional methods. This is for
the benefits associated with MIS, especially for
elderly patients. These include fewer
complications after surgeries, faster recovery,
and a shorter hospital stay. Guidewires are an
inevitable
3
part of most of these procedures. Thus, the
greater reliance on MIS for treating target
diseases implies growth in the global therapeutic
guidewire market. The research is global in
nature and covers detailed analysis on the market
in North America (U.S., Canada), Europe (U.K.,
Germany, France, Italy, Spain, Hungary, Belgium,
Netherlands Luxembourg, NORDIC Finland,
Sweden, Norway, Denmark, Poland, Turkey,
Russia, Rest of Europe), Latin America (Brazil,
Mexico, Argentina, Rest of Latin America),
Asia-Pacific (China, India, Japan, South Korea,
Indonesia, Singapore, Malaysia, Australia, New
Zealand, Rest of Asia-Pacific), Middle East and
Africa (Israel, GCC Saudi Arabia, UAE, Bahrain,
Kuwait, Qatar, Oman, North Africa, South Africa,
Rest of Middle East and Africa). In addition,
analysis comprising market size, Y-O-Y growth
opportunity analysis, market players competitive
study, investment opportunities, demand for
future outlook etc. has also been covered and
displayed in the research report. However, the
high cost associated with therapeutic guidewire
surgeries, the decrease in surgeries during
COVID-19, and the scarcity of proficient surgeons
are expected to operate as key restraints to the
growth of the global therapeutic guidewire market
over the forecast period. This report also
provides the existing competitive scenario of
some of the key players of the global
therapeutic guidewire market which includes
company profiling of Abbott., Cardinal Health.,
Boston Scientific Corporation, SP Medical A/S,
Teleflex Incorporated., Stryker, Medtronic,
Terumo Medical Corporation, Cook Group
Incorporated, BIOTRONIK SE Co. KG, and others.
The profiling enfolds key information of the
companies which encompasses business overview,
products and services, key financials and recent
news and developments. On the whole, the report
depicts detailed overview of the global
therapeutic guidewire market that will help
industry consultants, equipment manufacturers,
existing players searching for expansion
opportunities, new players searching
possibilities and other stakeholders to align
their market centric strategies according to the
ongoing and expected trends in the future.
4
Request Report Sample_at_ https//www.kennethresearch
.com/sample-request- 10042864 Kenneth Research
is a leading service provider for strategic
market research and consulting. We aim to
provide unbiased, unparalleled market insights
and industry analysis to help industries,
conglomerates and executives to take wise
decisions for their future marketing strategy,
expansion and investment etc. We believe every
business can expand to its new horizon, provided
a right guidance at a right time is available
through strategic minds. Our out of box thinking
helps our clients to take wise decision in order
to avoid future uncertainties. Contact for more
Info AJ Daniel Email sales_at_kennethresearch.com
U.S. Phone [phone]